15 Spinal Deformity Associated with Neurodegenerative Disease in Adults
Abstract
Neurodegenerative disease is an important, though often overlooked, etiology of spinal deformity in adults. Due to the complex etiology of their deformity and presence of comorbidities, these patients often have high complication and failure rates when surgical intervention is pursued. This chapter provides an overview of the clinical features and management strategies used to treat spinal deformity in patients with neurodegenerative conditions such as Parkinson’s and Alzheimer’s diseases.
15.1 Introduction
Neurodegenerative diseases represent a small but important portion of patients undergoing spinal deformity surgery. From 2001 to 2010, there were 1,347,359 patients who underwent thoracolumbar spinal fusion surgery (ICD9 8104–8108, 8134–8138) in the U.S. National Inpatient Sample (NIS) database, representing 20% of weighted U.S. hospitalizations. Of these patients, 146,268 (10.9%) were diagnosed with Parkinson’s disease, just one of the myriad of neurodegenerative disorders. Degenerative diseases of the central nervous system are characterized by a progressive loss of neurons with associated secondary changes in white matter tracts. The pattern of neuronal loss is selective, and symptoms can arise in patients with no history of neurologic deficits and without any clear inciting event. 1 Neurodegenerative diseases encompass a wide range of pathologies and thus are often grouped by affected anatomic regions of the central nervous system.
Degenerative diseases affecting the cerebral cortex manifest with dementia, a loss of cognitive function independent of the state of attention. These include Alzheimer’s disease (the most common neurodegenerative disease in adults), frontotemporal dementias including Pick’s disease, progressive supranuclear palsy, corticobasal degeneration, frontotemporal dementias without tau pathology, multi-infarct dementia, Creutzfeldt–Jakob disease, and neurosyphilis. Degenerative diseases of the basal ganglia and brainstem are characterized by pathological movements including rigidity, abnormal posturing, and chorea. These include Parkinson’s disease, multiple system atrophy, and Huntington’s disease. Spinocerebellar degenerative diseases are characterized by motor and sensory ataxia, spasticity, and sensorimotor peripheral neuropathy. This heterogeneous group of diseases includes spinocerebellar ataxias. Finally, degenerative diseases affecting motor neurons result in muscle denervation from loss of lower motor neuron input, including amyotrophic lateral sclerosis (ALS), bulbospinal atrophy (Kennedy’s syndrome), and spinal muscular atrophy.
Management of spinal deformity in patients with neurodegenerative disease, be it medical or operative, differs significantly from that of a patient with chronic degenerative disease. Patients with neurodegenerative disorders such as Parkinson’s and Alzheimer’s diseases present unique challenges and considerations to all aspects of care, including medical optimization, operative intervention, and rehabilitation. Given the complexity and importance of tailoring treatment to each patient, the goal of this chapter is to highlight the overarching principles and considerations when approaching spinal deformity in patients with neurodegenerative disease.
15.2 Etiology and Pathogenesis
A common deficiency among patients with neurodegenerative disease is a loss of the normal cellular mechanisms of degradation, 1 resulting in the development of cytotoxic protein aggregates characteristically recognized as inclusion bodies. In Huntington’s disease, an expanded polyglutamine repeat results in an aberrant form of the huntingtin protein. In Alzheimer’s disease, abnormal aggregates of the transmembrane protein Aβ elicit neurotoxic responses from astrocytes and microglia. Parkinson’s disease is characterized by an unexplained alteration of a normal cellular protein (α-synuclein) forming the hallmark protein aggregates known as Lewy’s bodies. In ALS, dysfunction of copper–zinc superoxide dismutase gene results in periodic acid–Schiff (PAS)-positive cytoplasmic inclusions of autophagic vacuoles. Each of these disease processes ultimately results in the loss of neuronal transmission, causing muscular spasticity or atrophy. The subsequent loss of muscular balance caused by these disorders finally culminates in those axial skeletal changes diagnosed as coronal and sagittal deformity.
15.3 Disease-Specific Deformity Characteristics and Comorbidities
A wide range of spinal deformities are seen in neurodegenerative conditions, including antecollis, lateral axial dystonia (LAD), camptocormia, and scoliosis.
15.3.1 Antecollis
In 1817, James Parkinson first described the disease that bears his name as “a propensity to bend the trunk forward” along with the following physical exam finding: “the chin is now almost immovably bent down upon the sternum.” 2 , 3 , 4 Later in 1886, Gerlier used the term “vertigeparalysant” to refer to the phenomenon of a dropped head associated with torticollis and pain of the occipital muscles that spread to the shoulders. 5 Meanwhile, in Japan, Miura in 1897 described “kubisagari,” or attacks of dropped head with weakness of the upper and lower extremities. 4 These represent the earliest descriptions of antecollis.
Antecollis is defined as significant (minimum of 45 degrees) neck flexion which may be partially overcome by voluntary or passive movement. Severity is variable, with some patients presenting with an inability to fully extend the neck against gravity but able to exert force against the resistance of the examiner’s hand. 6 , 7 Antecollis occurs in Parkinson’s disease resulting from dystonia of flexor neck muscles or weakness of extensor neck muscles. 4 Antecollis develops in 5 to 6% of patients with Parkinson’s disease, 3 , 4 , 8 yet it is also occasionally a component of multiple system atrophy, with shorter intervals between the onset of motor symptoms and antecollis. 7
15.3.2 Lateral Axial Dystonia
LAD is a general term used to describe the laterally flexed posture caused by extensor truncal dystonia, also known as pleurothotonus and Pisa syndrome. 9 , 10 First described by Ekbom et al in 1972 as a constellation of physical exam findings associated with neuroleptic therapy, 11 Pisa syndrome, reminiscent of the well-known Italian structure, is defined by significant (minimum of 10 degrees) lateral flexion, often with a component of backward axial rotation, that can be alleviated by passive mobilization or supine positioning. 12 LAD is characterized by continuous electromyography (EMG) activity of ipsilateral paraspinal muscles while standing or seated, though EMG activity is absent while recumbent. 9 Despite the often interchanging use of these terms, there is some controversy among authors regarding the etiology of these conditions (i.e., tardive neuroleptic syndromes vs. idiopathic primary dystonia) and possibility that they represent more than one clinical entity.
Pisa syndrome has been described among patients with Alzheimer’s disease, 13 , 14 multiple system atrophy, 15 Parkinson’s disease, 6 , 16 and ALS, 17 as well as in patients with dementia treated with cholinesterase inhibitors. 9 , 18 One series of 1,400 patients with Parkinson’s disease demonstrated 1.9% with classic features of Pisa syndrome, 9 which may be a precursor to the development of scoliosis in these patients. 6 , 9 Though there are documented cases of idiopathic Pisa syndrome, most cases are associated with the use of neuroleptic medications and respond well to adjustments or withdrawal of offending agents. 19 , 20
15.3.3 Camptocormia
In 1818, Sir Benjamin Collins Brodie described a “functionally bent back,” referring to what would later be called bent spine syndrome. 21 , 22 , 23 Camptocormia, derived from the Greek words “camptos” (bent) and “kormos” (trunk), is also known as the bent spine syndrome. 21 , 24 , 25 Camptocormia is defined as significant (minimum of 45 degrees) thoracolumbar flexion in the sagittal plane, with almost complete resolution in the supine position. 26 , 27 These patients frequently report a gradual, though occasionally subacute, sensation of being “pulled forward” with worsening of posture and pain after prolonged activity. Originally thought to be a psychogenic disorder, camptocormia is now considered to be of idiopathic origin or secondary to neuromuscular disease, including Parkinson’s disease, ALS, polymyositis, inclusion body myositis, muscular dystrophies, myasthenia gravis, and cervical dystonia. An associated condition is proximal myotonic myopathy characterized by progressive painful paraspinal muscle weakness exaggerated by exercise. 28 Other unusual cases of camptocormia have been reported in the literature and observed by these clinicians as well (Fig. 15‑1 a, b). In a 2010 Japanese case report, for example, a patient is illustrated with postherpetic abdominal wall paresis resulting in pseudohernia and 40-degree right convex deformity from T12 to L4. 29
Camptocormia in Parkinson’s disease is caused by myopathy resulting in axial dystonia, 30 resulting in an imbalance of spinal flexion and extension. Camptocormia secondary to neurodegenerative or neuromuscular disorder can be diagnosed by EMG, which reveals weakness of the paravertebral muscles and elevated creatinine kinase levels. Muscle biopsy in patients with Parkinson’s disease reveals disorganized myofibrils with intrafascicular fibrosis and fatty degeneration. 31 Magnetic resonance imaging (MRI) findings include early edema and swelling followed by fatty infiltration of paravertebral muscles. 32 , 33 Camptocormia occurs in 3 to 17.6% of patients with Parkinson’s disease. 24 , 25 , 34 , 35
15.3.4 Scoliosis
The earliest identification of spinal deformities including scoliosis dates back to Hippocrates, who described spinal curves in his book On Bones and Joints. 36 , 37 Traditional definitions of scoliosis summarize the vastly encompassing term as “lateral flexion not relieved by voluntary or passive movement, and lateral curvature of the spine of at least 10° as measured by the Cobb method with evidence of axial vertebral rotation on radiograph.” 38 Scoliosis should be differentiated from the previously described postural deformities including camptocormia, antecollis, and Pisa syndrome as a rigid deformity.
The vertebral column serves to provide support and balance to the human body. Specifically, the spine is the primary means by which the body maintains an upright posture and a horizontal gaze. Dubousset described a theoretical conus within which the whole body maintains an upright posture. His conus ranges from the narrower “cone of economy,” representing minimal exertion, to the “cone of maximum work,” which is the upper limit of energy expenditure. 39 , 40 Dubousset visualized a conus of balance for the standing position, in which the feet are located within a zone referred to as the “polygon of sustentation,” and the body, under the influence of muscle function and ligamentous support, can move in a conical fashion without moving the feet. The body adapts to changes in balance in order to regulate the center of gravity over the smallest perimeter possible. 41 This fundamental tendency toward equilibrium is what drives compensatory changes in the spine as it attempts to adapt to pathological processes either inherent to the spine or external to the spinal column such as neurodegenerative diseases.
Antecollis, camptocormia, and lateral truncal dystonia are postural deformities that can lead to rigid deformities including scoliosis. Specifically, the use of the term scoliosis pertaining to adult patients with neuromuscular diseases such as Parkinson’s disease is restricted to those spinal deformities not related to medical treatment such as L-dopa and not related to any clinical manifestations of the neuromuscular or neurodegenerative disease. Additionally, the direction of the convexity must not be related to the laterality of initial parkinsonian symptoms. 42 Scoliosis is more common in patients with Parkinson’s disease (ranging from 43 to 90% 42 , 43 , 44 ) compared to an age-matched population (ranging from 6 to 30% 45 , 46 ).
While sagittal alignment reflects how the anatomic shape of the spine permits an economical standing position, sagittal balance is a dynamic parameter and corresponds to the ability of the subject to maintain stability of the standing position. Patients with Parkinson’s disease have characteristically poor stability, often presenting with greater oscillations in the standing position and a significantly greater risk of fall. 47 In 2005, Sinaki et al demonstrated that patients with hyperkyphosis also present with significant loss of spinal erector muscles (erector spinae) and a compromised gait, leading to trunk shift and a higher risk of falling. 48
With regard to spinopelvic malalignment, patients with Parkinson’s disease present with a pattern of flexion of the spine, hips, and knees. Abnormal neuromuscular activation patterns can result in a greater tendency to forward bend, which can lead to global sagittal malalignment, a powerful driver of pain and disability. 49 Oh et al evaluated the incidence of sagittal malalignment in a series of patients with Parkinson’s disease and found that 42% had a sagittal vertical axis (SVA) measurement of greater than 50 mm. Furthermore, 51% of patients had spinopelvic mismatch (pelvic incidence minus lumbar lordosis [PI-LL]) greater than 10 degrees, suggesting that the severity of the Parkinson symptoms affects the ability to compensate with pelvic retroversion. 50 , 51 Lastly, it is important to note that some patients with Parkinson’s disease may present with de novo or progression of idiopathic scoliosis independent of their neurodegenerative pathology.
An emerging concept with respect to the etiology of spinal pathologies is that there are subclinical changes in the neuromuscular quality of the soft tissues that cause progressive deformity through a mechanism that has not yet been elucidated.
It is not known whether muscle degeneration leads to sagittal imbalance, or whether sagittal malalignment is the premise for muscle degeneration that then drives pain and disability. Further study of the role of “soft tissues” would improve our understanding of compensatory mechanisms (knee flexion, pelvic retroversion, hip hyperextension) that are used to maintain posture in adults with spinal deformity. Future aims to surgically address deformity must take into account this complex pathophysiology in addition to each of these compensatory mechanisms. In summary, understanding the nonbony factors that drive adult neurodegenerative disease will deepen our understanding of adult spinal conditions and optimize treatment strategies.
15.4 Disorder-Specific Techniques
15.4.1 Nonoperative Treatment
An appropriate history, physical exam, and imaging workup must be obtained for any patient with a neurodegenerative disorder prior to treatment of a spinal deformity. Caution must be taken to rule out other disorders, such as inflammatory myopathies, that are capable of resembling neurodegenerative disorders such as Parkinson’s disease. Moreover, these conditions can similarly be related to the development of spinal deformity, though their responses to treatment differ enormously. This possibility demands the accurate diagnosis prior to intervention. Accordingly, consultation with a neurologist is reasonable to ensure the diagnosis whenever in question and to optimize medical treatment.
Conservative treatment begins with treatment of the primary neurodegenerative condition. While there are no curative treatments for neurodegenerative diseases, various medications have been developed to temporize symptoms and maximize function in these patients. 1 As consultant physicians, spine specialists must appreciate the risks and benefits of proposed medications with respect to spinal pathologies. For example, L-dopa is effective for the treatment of Parkinson symptoms such as rigidity and akinesia but may exacerbate camptocormia. 25 , 26 With respect to treating spinal pathology, nonoperative treatments may include bracing, physical therapy, and injections, with possible adjunctive use of more recently developed technologies such as deep brain stimulation (DBS).
15.4.2 Operative Treatment
Traditionally, the goals of surgical correction of scoliosis involve restoration of coronal and sagittal alignment. 52 Specific correction of sagittal malalignment can offer major improvements in quality and functionality in adult spinal deformity patients 53 , 54 , 55 ; however, there are many considerations when contemplating surgical treatment in these patients. Moreover, the management of deformity in adult patients with neuromuscular diseases such as cerebral palsy remains challenging with little empiric evidence to support guidelines for operative treatment. 56 Despite the absence of studies suggesting optimal spinopelvic parameters in patients with neurodegenerative disease, experience of these clinicians suggests goals similar to those of degenerative scoliosis as follows: pelvic tilt (PT) < 25 deegrees, 57 C7–S1 SVA <50 mm, 49 , 58 PI-LL < 10 degrees, 54 , 57 , 59 and T1 pelvic angle < 20 degrees. 60
Technical Considerations
Patients with neurodegenerative disease often have major deformities localized to the thoracolumbar region. These deformities make alignment goals more difficult to define in the setting of limited reserve, combined with both coronal and sagittal malalignment. These patients have a limited ability to compensate through pelvic retroversion or thoracic hypokyphosis, 61 thereby highlighting the importance of obtaining optimal SVA, PT, and PI-LL with correction. On the other hand, long fusions of the spine may create an unfavorable biomechanical state with the introduction of a long lever arm that may compromise the compensatory mechanisms used to recover the center of mass above the feet. This can reduce the width of the cone of stability of these patients and contribute to fall risk. A long fusion in patients with an intrinsic loss of stability, such as in cases of neurodegenerative disease, can result in correct alignment but poor balance and gross instability, ultimately leading to repeated falls. This sacrifice of stability should be taken into account when treating neurodegenerative patients with sagittal malalignment. 51